Hypertriglyceridemia
Open Access
- 22 March 2013
- Vol. 5 (3), 981-1001
- https://doi.org/10.3390/nu5030981
Abstract
Hypertriglyceridemia (HTG) is commonly encountered in lipid and cardiology clinics. Severe HTG warrants treatment because of the associated increased risk of acute pancreatitis. However, the need to treat, and the correct treatment approach for patients with mild to moderate HTG are issues for ongoing evaluation. In the past, it was felt that triglyceride does not directly contribute to development of atherosclerotic plaques. However, this view is evolving, especially for triglyceride-related fractions and variables measured in the non-fasting state. Our understanding of the etiology, genetics and classification of HTG states is also evolving. Previously, HTG was considered to be a dominant disorder associated with variation within a single gene. The old nomenclature includes the term “familial” in the names of several hyperlipoproteinemia (HLP) phenotypes that included HTG as part of their profile, including combined hyperlipidemia (HLP type 2B), dysbetalipoproteinemia (HLP type 3), simple HTG (HLP type 4) and mixed hyperlipidemia (HLP type 5). This old thinking has given way to the idea that genetic susceptibility to HTG results from cumulative effects of multiple genetic variants acting in concert. HTG most is often a “polygenic” or “multigenic” trait. However, a few rare autosomal recessive forms of severe HTG have been defined. Treatment depends on the overall clinical context, including severity of HTG, concomitant presence of other lipid disturbances, and the patient's global risk of cardiovascular disease. Therapeutic strategies include dietary counselling, lifestyle management, control of secondary factors, use of omega-3 preparations and selective use of pharmaceutical agents.Keywords
This publication has 76 references indexed in Scilit:
- Lipase maturation factor 1: A lipase chaperone involved in lipid metabolismBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2012
- Excess of Rare Variants in Non–Genome-Wide Association Study Candidate Genes in Patients With HypertriglyceridemiaCirculation: Cardiovascular Genetics, 2012
- Incidence of pancreatitis, secondary causes, and treatment of patients referred to a specialty lipid clinic with severe hypertriglyceridemia: a retrospective cohort studyLipids in Health and Disease, 2011
- An Increased Burden of Common and Rare Lipid-Associated Risk Alleles Contributes to the Phenotypic Spectrum of HypertriglyceridemiaArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Triglycerides and Heart DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Genetic determinants of plasma triglyceridesJournal of Lipid Research, 2011
- Biological, clinical and population relevance of 95 loci for blood lipidsNature, 2010
- Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemiaNature Genetics, 2010
- Effects of Combination Lipid Therapy in Type 2 Diabetes MellitusThe New England Journal of Medicine, 2010
- A polygenic basis for four classical Fredrickson hyperlipoproteinemia phenotypes that are characterized by hypertriglyceridemiaHuman Molecular Genetics, 2009